Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 262

Similar articles for PubMed (Select 17202206)

1.
2.

Identification of cellular proteins that maintain retroviral epigenetic silencing: evidence for an antiviral response.

Poleshko A, Palagin I, Zhang R, Boimel P, Castagna C, Adams PD, Skalka AM, Katz RA.

J Virol. 2008 Mar;82(5):2313-23. Epub 2007 Dec 19.

3.

Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells.

Bartoli A, Fettucciari K, Fetriconi I, Rosati E, Di Ianni M, Tabilio A, Delfino DV, Rossi R, Marconi P.

Pharmacol Res. 2003 Jul;48(1):111-8.

PMID:
12770523
4.

Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase.

Chen WY, Bailey EC, McCune SL, Dong JY, Townes TM.

Proc Natl Acad Sci U S A. 1997 May 27;94(11):5798-803.

5.

Relaxed repression of herpes simplex virus type 1 genomes in Murine trigeminal neurons.

Terry-Allison T, Smith CA, DeLuca NA.

J Virol. 2007 Nov;81(22):12394-405. Epub 2007 Sep 12.

6.

Inhibition of histone deacetylases induces bovine leukemia virus expression in vitro and in vivo.

Merezak C, Reichert M, Van Lint C, Kerkhofs P, Portetelle D, Willems L, Kettmann R.

J Virol. 2002 May;76(10):5034-42.

7.

Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.

Law AY, Lai KP, Lui WC, Wan HT, Wong CK.

Exp Cell Res. 2008 Oct 1;314(16):2975-84. doi: 10.1016/j.yexcr.2008.07.002. Epub 2008 Jul 9.

PMID:
18652825
9.
10.

Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.

Klan N, Seuter S, Schnur N, Jung M, Steinhilber D.

Biol Chem. 2003 May;384(5):777-85.

PMID:
12817474
11.

The histone deacetylase inhibitor trichostatin A reduces nickel-induced gene silencing in yeast and mammalian cells.

Sutherland JE, Peng W, Zhang Q, Costa M.

Mutat Res. 2001 Aug 8;479(1-2):225-33.

PMID:
11470494
12.

Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells.

Chou SD, Khan AN, Magner WJ, Tomasi TB.

Int Immunol. 2005 Nov;17(11):1483-94. Epub 2005 Oct 6.

13.
14.

Epigenetic regulation of cytomegalovirus major immediate-early promoter activity in transgenic mice.

Mehta AK, Majumdar SS, Alam P, Gulati N, Brahmachari V.

Gene. 2009 Jan 1;428(1-2):20-4. doi: 10.1016/j.gene.2008.09.033. Epub 2008 Oct 10.

PMID:
18976699
15.
16.

Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications.

Yao S, Sukonnik T, Kean T, Bharadwaj RR, Pasceri P, Ellis J.

Mol Ther. 2004 Jul;10(1):27-36.

PMID:
15233939
17.

Effect of trichostatin A and 5-Aza-2'-deoxycytidine on transgene reactivation and epigenetic modification in transgenic pig fibroblast cells.

Kong Q, Wu M, Wang Z, Zhang X, Li L, Liu X, Mu Y, Liu Z.

Mol Cell Biochem. 2011 Sep;355(1-2):157-65. doi: 10.1007/s11010-011-0849-7. Epub 2011 May 4.

PMID:
21541675
18.

Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer.

Feng W, Lu Z, Luo RZ, Zhang X, Seto E, Liao WS, Yu Y.

Int J Cancer. 2007 Apr 15;120(8):1664-8.

PMID:
17230502
19.

Green fluorescent protein retroviral vectors: low titer and high recombination frequency suggest a selective disadvantage.

Hanazono Y, Yu JM, Dunbar CE, Emmons RV.

Hum Gene Ther. 1997 Jul 20;8(11):1313-9.

PMID:
9295126
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk